Form 8-K Clovis Oncology, Inc. For: May 06
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
UPDATE: Clovis Oncology (CLVS) Misses Q1 EPS by 4c (Correction)
May 6, 2015 3:56 PM EDT(Updated - May 6, 2015 3:57 PM EDT)
Clovis Oncology (NASDAQ: CLVS) reported Q1 EPS of ($1.86), $0.04 worse than the analyst estimate of ($1.82). Revenue for the quarter came in at $0 , versus $13.6 million reported last year.
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
... More
